LIFECORE BIOMEDICAL, INC. \DE\ Quarterly Interest Expense in USD from Q3 2010 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Lifecore Biomedical, Inc. \De\ quarterly/annual Interest Expense history and growth rate from Q3 2010 to Q2 2023.
  • Lifecore Biomedical, Inc. \De\ Interest Expense for the quarter ending May 28, 2023 was $5.92M, a 98.9% increase year-over-year.
  • Lifecore Biomedical, Inc. \De\ Interest Expense for the twelve months ending May 28, 2023 was $17.6M, a 13.5% increase year-over-year.
  • Lifecore Biomedical, Inc. \De\ annual Interest Expense for 2022 was $17.6M, a 13.5% increase from 2021.
  • Lifecore Biomedical, Inc. \De\ annual Interest Expense for 2021 was $15.6M, a 74.1% increase from 2020.
  • Lifecore Biomedical, Inc. \De\ annual Interest Expense for 2020 was $8.93M, a 92.3% increase from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $17.6M $5.92M +$2.95M +98.9% Feb 27, 2023 May 28, 2023 10-K 2024-03-20
Q1 2023 $14.7M $4.86M +$1.18M +32.1% Nov 28, 2022 Feb 26, 2023 10-K 2024-03-20
Q4 2022 $13.5M $3.62M +$857K +31% Aug 29, 2022 Nov 27, 2022 10-K 2024-03-20
Q3 2022 $12.7M $3.25M -$2.88M -47% May 30, 2022 Aug 28, 2022 10-K 2024-03-20
Q2 2022 $15.6M $2.98M -$132K -4.24% Feb 28, 2022 May 29, 2022 10-K 2024-03-20
Q1 2022 $15.7M $3.68M +$1.11M +43.5% Nov 29, 2021 Feb 27, 2022 10-K 2024-03-20
Q4 2021 $14.6M $2.77M +$1.17M +73.4% Aug 30, 2021 Nov 28, 2021 10-K 2024-03-20
Q3 2021 $13.4M $6.13M +$4.47M +268% May 31, 2021 Aug 29, 2021 10-K 2024-03-20
Q2 2021 $8.93M $3.11M +$4.92M Mar 1, 2021 May 30, 2021 10-K 2024-03-20
Q1 2021 $4.01M $2.56M +$351K +15.9% Nov 30, 2020 Feb 28, 2021 10-K 2024-03-20
Q4 2020 $3.66M $1.6M -$573K -26.4% Aug 31, 2020 Nov 29, 2020 10-K 2024-03-20
Q3 2020 $4.24M $1.67M -$410K -19.8% Jun 1, 2020 Aug 30, 2020 10-K 2024-03-20
Q2 2020 $4.65M -$1.81M Feb 24, 2020 May 31, 2020 10-K/A 2023-03-16
Q1 2020 $2.21M +$440K +24.8% Nov 25, 2019 Feb 23, 2020 10-Q 2021-04-08
Q4 2019 $2.17M Aug 26, 2019 Nov 24, 2019 10-Q 2021-01-07
Q3 2019 $2.08M May 27, 2019 Aug 25, 2019 10-Q 2020-10-07
Q1 2019 $1.77M Nov 26, 2018 Feb 24, 2019 10-Q 2020-04-03
Q3 2016 $2.14M $653K +$151K +30.1% May 30, 2016 Aug 28, 2016 10-Q 2016-09-29
Q2 2016 $1.99M $562K +$98K +21.1% Feb 29, 2016 May 29, 2016 10-K 2016-08-01
Q1 2016 $1.89M $484K -$26K -5.1% Nov 30, 2015 Feb 28, 2016 10-Q 2016-03-30
Q4 2015 $1.92M $439K -$33K -6.99% Aug 31, 2015 Nov 29, 2015 10-Q 2016-01-07
Q3 2015 $1.95M $502K +$119K +31.1% Jun 1, 2015 Aug 30, 2015 10-Q 2016-09-29
Q2 2015 $1.83M $464K +$71K +18.1% Mar 2, 2015 May 31, 2015 10-K 2016-08-01
Q1 2015 $1.76M $510K +$120K +30.8% Dec 1, 2014 Mar 1, 2015 10-Q 2016-03-30
Q4 2014 $1.64M $472K +$36K +8.26% Sep 1, 2014 Nov 30, 2014 10-Q 2016-01-07
Q3 2014 $1.6M $383K -$48K -11.1% Jun 2, 2014 Aug 31, 2014 10-Q 2015-10-01
Q2 2014 $1.65M $393K -$89K -18.5% Feb 24, 2014 May 25, 2014 10-K 2016-08-01
Q1 2014 $1.74M $390K -$97K -19.9% Nov 25, 2013 Feb 23, 2014 10-Q 2015-04-02
Q4 2013 $1.84M $436K -$62K -12.5% Aug 26, 2013 Nov 24, 2013 10-Q 2015-01-09
Q3 2013 $1.9M $431K -$110K -20.3% May 27, 2013 Aug 25, 2013 10-Q 2014-10-08
Q2 2013 $2.01M $482K +$45K +10.3% Feb 25, 2013 May 26, 2013 10-K 2015-07-31
Q1 2013 $1.96M $487K +$334K +218% Nov 26, 2012 Feb 24, 2013 10-Q 2014-03-28
Q4 2012 $1.63M $498K +$335K +206% Aug 27, 2012 Nov 25, 2012 10-Q 2014-01-03
Q3 2012 $1.29M $541K +$365K +207% May 28, 2012 Aug 26, 2012 10-Q 2013-09-26
Q2 2012 $929K $437K +$249K +132% Feb 27, 2012 May 27, 2012 10-K 2014-08-01
Q1 2012 $680K $153K -$43K -21.9% Nov 28, 2011 Feb 26, 2012 10-Q 2013-04-04
Q4 2011 $723K $163K -$46K -22% Aug 29, 2011 Nov 27, 2011 10-Q 2013-01-04
Q3 2011 $769K $176K -$51K -22.5% May 30, 2011 Aug 28, 2011 10-Q/A 2013-01-02
Q2 2011 $820K $188K Feb 28, 2011 May 29, 2011 10-K 2013-08-07
Q1 2011 $196K Nov 29, 2010 Feb 27, 2011 10-Q 2012-03-28
Q4 2010 $209K Aug 30, 2010 Nov 28, 2010 10-Q 2012-01-05
Q3 2010 $227K Jun 1, 2010 Aug 29, 2010 10-Q 2011-10-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.